Wsol, Vladimir <br/><br/>
Aldo-keto reductases (AKR) from the AKR1C subfamily catalyze the carbonyl reduction of the novel anticancer drug oracin in man.  [electronic resource] 

 -  Toxicology  Sep 2007 
 - 111-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0300-483X 
<br/><br/><label>Standard No.: </label>10.1016/j.tox.2007.05.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>20-Hydroxysteroid Dehydrogenases--chemistry<br/>Alcohol Oxidoreductases--metabolism<br/>Aldehyde Reductase<br/>Aldo-Keto Reductases<br/>Antineoplastic Agents--chemistry<br/>Catalysis<br/>Cytosol--enzymology<br/>Electrophoresis, Polyacrylamide Gel<br/>Ethanolamines--chemistry<br/>Humans<br/>Hydroxysteroid Dehydrogenases--chemistry<br/>Inactivation, Metabolic<br/>Isoquinolines--chemistry<br/>Liver--cytology<br/>Molecular Structure<br/>Oxidation-Reduction<br/>Oxidoreductases--chemistry<br/>Stereoisomerism<br/>Substrate Specificity